Genomic analysis of an Argentinean PSP cohort
Objective: Identify genomic variants present in Argentinean PSP cases and assess their genetic background. Background: Progressive supranuclear palsy (PSP) is a primary tauopathy with low…Cognitive & Clinical Correlates of Quality of Life in Probable Progressive Supranuclear Palsy
Objective: To examine the relationship between cognitive, executive, motor & autonomic function, neuropsychiatric symptoms, and health-related quality of life (HRQoL) in patients with progressive supranuclear…Metabolic-Structural Patterns Across Progressive Supranuclear Palsy Clinical Variants: a Multimodal PET-MRI Study
Objective: To characterize patterns of regional glucose hypometabolism on Fluorodeoxyglucose (FDG)-PET and structural atrophy on MRI across clinical variants of progressive supranuclear palsy (PSP). Background:…Fluid Biomarkers and the 4R-Tauopathies
Objective: To investigate the prevalence and clinical relevance of AD co-pathology, assessed through fluid biomarkers, in patients with clinical 4R-tauopathies. Background: 4R-tauopathies are neurodegenerative diseases…Evaluation of Semantic Space Search Metrics in Phonemic Fluency: Comparison among Basal Ganglia Disorders and Healthy Controls
Objective: Phonemic verbal fluency reflects executive function and involves both within-category lexical retrieval (cluster size) and switching between categories. We compared semantic search behavior in…Normal Pressure Hydrocephalus Imaging Markers in Movement Disorders: Comparison of Parkinson’s Disease, Essential Tremor, Dystonia, and Progressive Supranuclear Palsy
Objective: Parkinson’s Disease (PD), Progressive Supranuclear Palsy (PSP), Essential Tremor (ET), Dystonia (DYT), and Normal Pressure Hydrocephalus (NPH) may show overlapping clinical and radiological findings.…Young onset Parkinson’s disease patient who has GBA1 pathogenic variant exhibiting progressive supranuclear palsy phenotype
Objective: We experience the GBA1 gene related YOPD who showed the progressive supranuclear palsy (PSP) phenotype. Background: Glucocerebrosidase (GBA1) gene mutations are well-known genetic risk…Interleukin 6 in the assessment of Parkinson’s disease and Progressive Supranuclear Palsy
Objective: The aim of this research is to analyze the relevance of serum interleukin 6 levels in the evaluation of Parkinson’s disease (PD) and Progressive…POLG-Related Disease Mimicking Progressive Supranuclear Palsy with Selective Vertical Gaze Restriction
Objective: To describe a patient with a pathogenic POLG mutation presenting with sensory neuropathy, ataxia, recurrent falls, and supranuclear gaze palsy initially misdiagnosed as progressive…Sex Differences in Disease Severity and Impact for Progressive Supranuclear Palsy and Corticobasal Syndrome
Objective: Assess sex differences in disease severity, quality of life (QOL) and caregiver burden in early- and late-onset progressive supranuclear palsy (PSP) and corticobasal syndrome…
- 1
- 2
- 3
- …
- 49
- Next Page »